Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 214 | 137 | 305 | 125 | 402 |
| Cost of Goods | 153 | 87 | 156 | 74 | 275 |
| Gross Profit | 61 | 50 | 149 | 50 | 126 |
| Operating Expenses | 1,332 | 1,127 | 1,289 | 1,104 | 1,020 |
| Operating Income | -1,271 | -1,077 | -1,140 | -1,053 | -894 |
| Interest Expense | 1 | 1 | 1 | 2 | 2 |
| Other Income | -9 | 11 | -2 | 136 | 13 |
| Pre-tax Income | -1,281 | -1,067 | -1,143 | -919 | -883 |
| Net Income Continuous | -1,281 | -1,067 | -1,143 | -919 | -883 |
| Net Income | $-1,281 | $-1,067 | $-1,143 | $-919 | $-883 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EBITDA(a) | $-1,208 | $-994 | $-1,072 | $-856 | $-799 |